Cholinergic mechanisms and cataplexy in dogs.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002385:Cataplexy / Q000503:physiopathology*; D004285:Dogs; D005260:Female; D006801:Humans; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D009388:Neostigmine / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D010277:Parasympathomimetics / Q000494:pharmacology*; D010830:Physostigmine / Q000494:pharmacology; D011950:Receptors, Cholinergic / Q000502:physiology*; D011976:Receptors, Muscarinic / Q000502:physiology; D012601:Scopolamine / Q000494:pharmacology
D010276:Parasympatholytics; D010277:Parasympathomimetics; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D009388:Neostigmine; D008464:Mecamylamine; D009538:Nicotine; D001285:Atropine; D010830:Physostigmine; D012601:Scopolamine